Response Guided Therapy (RGT) for Boceprevir Combined With Peginterferon Alpha-2b Plus Ribavirin in Naive Hispanic Patients With Genotype 1 Hepatitis C Infection.
Phase of Trial: Phase IV
Latest Information Update: 03 Jul 2015
At a glance
- Drugs Boceprevir (Primary) ; Peginterferon alfa-2b; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 01 Dec 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
- 09 Jul 2012 Additional lead trial centre identified as reported by ClinicalTrials.gov record.
- 09 Nov 2011 New trial record